Modulation of the antitumor and biochemical properties of bis(diphenylphosphine)ethane with metals.
暂无分享,去创建一个
S. Crooke | C. Mirabelli | R. Johnson | C. Sung | L. Faucette | R K Johnson | C K Mirabelli | F L McCabe | L F Faucette | C M Sung | S T Crooke | F. McCabe | R M Snyder | J P Zimmerman | M Whitman | J C Hempel | J. Hempel | J. Zimmerman | R. M. Snyder | M. Whitman
[1] K. Downey,et al. Degradation of DNA by 1,-10-phenanthroline. , 1980, Biochemical and biophysical research communications.
[2] D. Petering,et al. Comparative cytotoxic and biochemical effects of ligands and metal complexes of alpha-N-heterocyclic carboxaldehyde thiosemicarbazones. , 1979, Journal of medicinal chemistry.
[3] I. Fidler,et al. The pathogenesis of cancer metastasis , 1980, Nature.
[4] A. Krishan,et al. 1,10-Phenanthroline inhibition of lymphoblast cell cycle. , 1977, Cancer research.
[5] S. Crooke,et al. Deoxyribonucleic acid breaks produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper. , 1984, Biochemistry.
[6] N. Tanaka,et al. DNA strand scission induced by adriamycin and aclacinomycin A. , 1979, The Journal of antibiotics.
[7] M. R. Churchill,et al. Molecules with an M4X4 core. 10. Failure of the 1:1:1 tricyclohexylphosphine-copper(I)-chloride complex to form a tetramer. Crystal structure of dimeric (tricyclohexylphosphine)copper(I) chloride, [(P(cHx)3)CuCl]2 , 1979 .
[8] S. Crooke,et al. Effects of coordinated gold compounds on in vitro and in situ DNA replication. , 1985, Biochemical pharmacology.
[9] S. Crooke,et al. Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes. , 1986, Journal of medicinal chemistry.
[10] S. Crooke,et al. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. , 1985, Cancer research.
[11] S. Crooke,et al. Mechanism of deoxyribonucleic acid breakage induced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper: role for cuprous ion and oxygen free radicals. , 1984, Biochemistry.
[12] L. Pickart,et al. Inhibition of the growth of cultured cells and an implanted fibrosarcoma by aroylhydrazone analogs of the Gly-His-Lys-Cu(II) complex. , 1983, Biochemical pharmacology.
[13] L. Loeb,et al. Zinc in DNA polymerases. , 1971, Biochemical and biophysical research communications.
[14] E. Chargaff,et al. DNA polymerase of chicken embryo: purification and properties. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Carrano,et al. Inhibition of the RNA dependent DNA polymerase and the malignant transforming ability of Rous sarcoma virus by thiosemicarbazone-transition metal complexes. , 1978, Bioinorganic chemistry.
[16] Y. Sugiura. Bleomycin-iron complexes. Electron spin resonance study, ligand effect, and implication for action mechanism , 1980 .
[17] A. Camus,et al. Complexes of Cu(I) halides with bis(diphenylphosphino)methane and 1,2-bis(diphenylphosphino)ethane , 1972 .
[18] E. Weinberg. Iron in neoplastic disease. , 1983, Nutrition and cancer.
[19] E. Sausville,et al. A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. , 1976, Biochemical and biophysical research communications.
[20] P. L. Bellon,et al. Crystal and molecular structure of dichlorotris-[1,2-bis(diphenylphosphino)ethane]dicopper(I)–bisacetone , 1972 .
[21] A. Lorber,et al. Screening trial with the coordinated gold compound auranofin using mouse lymphocyte leukemia P388. , 1981, Cancer research.
[22] A. Shulman,et al. Action of 1,10-phenanthroline transition metal chelates on P388 mouse lymphocyte leukaemic cells. , 1977, Chemico-biological interactions.
[23] S. Crooke,et al. Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions. , 1986, Biochemical pharmacology.
[24] S. Crooke,et al. Cellular interactions of auranofin and a related gold complex with RAW 264.7 macrophages. , 1987, Biochemical pharmacology.
[25] P. Rao,et al. CHAPTER 17 – Effects of Temperature on the Mitotic Cycle of Normal and Synchronized Mammalian Cells , 1966 .
[26] H. Skipper,et al. The inhibition of growth of sarcoma 180 by combinations of B6-antagonists and acid hydrazides. , 1956, Cancer research.